NCI ComboMatch Study

NRG Oncology is soliciting concepts for the NCI ComboMatch study. This trial will focus on rational combinations of agents supported by preclinical in vivo evidence. Submission Due Date: June 25, 2019.  Please note that IO combinations are NOT permitted for the ComboMatch study.  Read more

This message was sent from to
Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103

Update Profile/Email Address | Forward Email | Report Abuse